J. Goldman & CO LP Teva Pharmaceutical Industries LTD Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $172,530 - $234,899	-13,500 Reduced 50.0%	13,500 $219,000
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $5.35 Million - $7.66 Million	-715,500 Reduced 96.36%	27,000 $275,000
Q2 2023 Aug 14, 2023	BUY	$7.2 - $9.47 $5.35 Million - $7.03 Million	742,500 New	742,500 $5.59 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.